Odyssey Therapeutics

“Odyssey’s accomplished team of scientists and executives with numerous prior successes in discovery, development and commercialization has made tremendous progress in only two years. Dr. Glick has successfully created a sustainable and capital-efficient model that primes Odyssey to be a hub for immunology and oncology therapeutic innovation, and I look forward to working with him, the board and leaders on the management team in the years ahead.” Dr. Lorence Kim, co-founder and managing partner of Ascenta Capital Today, we announce the closing of a $101 million Series C financing round led by Ascenta Capital with participation from new and existing investors, and welcome Dr. Lorence Kim to our board of directors. This funding will support the advancement of multiple programs into clinical studies and the continuation of investment in discovery to build a sustainable model for therapeutic innovation. Read the full press release: https://lnkd.in/gHVi7K2q #Biotech #DrugDiscovery #PrecisionMedicine #Therapeutics

Meet today’s #EmployeeSpotlight, Maria (Dai) Tianero-McIntosh, Associate Director of Natural Products Enabling Sciences at #TeamOdyssey. Dai joined Odyssey nearly three years ago to immerse herself in drug discovery and development, learning from industry leaders and colleagues with a proven track record. She is particularly excited about reintegrating Natural Products into discovery pipelines. Dai's favorite aspect of her job is working alongside colleagues who come from various backgrounds and possess a wide range of expertise. Outside of work, Dai loves exploring new places around Boston and New England with her husband and their two young children. They enjoy visiting beaches 🏖️, gardens 🌺, and engaging in various family-friendly activities.

Our next #EmployeeSpotlight features Jim Ferrucci, Corporate Controller. Jim joined #TeamOdyssey last year, working with colleagues across all functions to learn about the fascinating science behind drug discovery and development. He believes in our success because everyone is driven, passionate about making a difference, and committed to our mission. Outside of work, Jim enjoys spending time with his wife and two daughters, playing in a hockey league, saltwater fishing, and golfing.

Meet today’s #EmployeeSpotlight Laura Preiss, Director of Protein Therapeutics. Laura joined #TeamOdyssey 2.5 years ago, drawn by the excellent science and outstanding team members. Each and every morning, it's the stimulating and inspiring scientific discussions that draw Laura to Odyssey. Outside of work, Laura enjoys memorable experiences like road trips through Florida, finds inspiration in Yotam Ottolenghi's cookbooks, and indulges in caring for her orchids. We’re happy to have her here at Odyssey!

Yesterday, Odyssey's Chief Data Officer Joseph Mcdonald joined industry leaders from Johnson & Johnson Innovative Medicine, BigHat Biosciences, Sequome, and Samsara BioCapital for a panel discussion on the opportunities and challenges of using #AI and #ML tools for hit identification, multiparameter optimization, and in vivo property prediction to accelerate #DrugDiscovery in small molecules. During the session they were asked for their opinions on the impact of AI/ML in the industry over the next three to five years. Joe shared: “It could be that we will see new ways of monitoring patients, where instead of just using the maximum tolerated dose, we use machine learning to monitor patients more effectively. This allows us to titrate their dose, so treatments are effective and avoid toxicology risks.” Thank you, Biotechnology Innovation Organization, for hosting us and orchestrating an amazing event! #BIO2024

“What we want ultimately are scientists to leverage machine learning to see and observe trends, while using their own scientific knowledge as a filter, and be better as a result of seeing those ideas from machine learning.” Today Joseph Mcdonald, Odyssey's Chief Data Officer, participated in a #BIO2024 panel discussion titled “AI and Machine Learning Transforming R&D and Business.” Joe highlighted the power of #AI and #ML in drug discovery and emphasized the crucial role of scientists in interpreting and utilizing these insights. He shared how Odyssey has a multi-disciplinary team of scientists who understand drug discovery and can effectively integrate machine learning into decision-making processes. Joe will participate in another panel tomorrow from 11:00 a.m. to 12:00 p.m. PT in section 30ABC for a session titled “Using AI/ML for Identification and Optimization of Therapeutic Molecules.” We encourage those attending #BIO2024 to stop by and listen in.

Odyssey's Chief Data Officer, Joseph Mcdonald, will be participating in two panel sessions at the annual Biotechnology Innovation Organization International Convention in San Diego next week, each on different topics surrounding #AI. #BIO2024 #DigitalHealth For full panel information, visit https://lnkd.in/gbwSz8HD or see below👇 🎤 Panel: AI/ML is Transforming R&D and Business 📅 Date/Time: Tuesday, June 4, from 1:45 p.m. to 2:45 p.m. PT Joe will accompany other leaders across big pharma and emerging biotech to discuss how AI and ML technologies can impact business strategy, enable efficiency, and help drive partnerships. 🎤 Panel: Using AI/ML for Identification and Optimization of Therapeutic Molecules 📅 Date/Time: Wednesday, June 5, from 11:00 a.m. to 12:00 p.m. PT Assembled by @Johnson & Johnson, Joe will join other experts to discuss the opportunities, challenges, and approaches to unlocking the potential of #AI and #MachineLearning in #DrugDiscovery.

At Odyssey, we are pioneering revolutionary precision immunomodulators to improve the lives of patients living with serious diseases. Today, on World IBD Day, we raise awareness and support for those in the fight against inflammatory bowel diseases (#IBD). Learn more about Odyssey’s pipeline of immunology programs in development here: https://lnkd.in/eeJTmwCt #IBDhasnoborders #worldibdday2024

Introducing Caroline Farrington, #TeamOdyssey Senior Scientist. Caroline joined our team a year and a half ago to enhance her expertise in biotech alongside a talented and knowledgeable team. Each day, she's inspired by the opportunity to make a meaningful difference in the lives of future patients. Outside work, Caroline enjoys ballet classes, early morning hikes with her dogs and husband, gardening, reading, and swimming in the ocean. #EmployeeSpotlight

Odyssey's Chief Medical Officer, Dr. Jeremy Sokolove, will be attending Digestive Disease Week in Washington, D.C. from May 18-21, where he will connect with other leading #gastroenterology clinicians and experts. Digestive Disease Week® (DDW) event info here: https://ddw.org/ #DDW2024